Literature DB >> 20336655

Genetic variation in G72 correlates with brain activation in the right middle temporal gyrus in a verbal fluency task in healthy individuals.

Axel Krug1, Valentin Markov, Sören Krach, Andreas Jansen, Klaus Zerres, Thomas Eggermann, Tony Stöcker, N Jon Shah, Markus M Nöthen, Alexander Georgi, Jana Strohmaier, Marcella Rietschel, Tilo Kircher.   

Abstract

The D-amino acid oxidase activator gene (G72) has been found associated with several psychiatric disorders such as schizophrenia, major depression, and bipolar disorder. Impaired performance in verbal fluency tasks is an often replicated finding in the mentioned disorders. In functional neuroimaging studies, this dysfunction has been linked to signal changes in prefrontal and lateral temporal areas and could possibly constitute an endophenotype. Therefore, it is of interest whether genes associated with the disorders, such as G72, modulate verbal fluency performance and its neural correlates. Ninety-six healthy individuals performed a semantic verbal fluency task while brain activation was measured with functional MRI. All subjects were genotyped for two single nucleotide polymorphisms (SNP) in the G72 gene, M23 (rs3918342) and M24 (rs1421292), that have previously shown association with the above-mentioned disorders. The effect of genotype on brain activation was assessed with fMRI during a semantic verbal fluency task. Although there were no differences in performance, brain activation in the right middle temporal gyrus (BA 39) and the right precuneus (BA 7) was positively correlated with the number of M24 risk alleles in the G72 gene. G72 genotype does modulate brain activation during language production on a semantic level in key language areas. These findings are in line with structural and functional imaging studies in schizophrenia, which showed alterations in the right middle temporal gyrus. Hum Brain Mapp, 2010.
© 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20336655      PMCID: PMC6870361          DOI: 10.1002/hbm.21005

Source DB:  PubMed          Journal:  Hum Brain Mapp        ISSN: 1065-9471            Impact factor:   5.038


  53 in total

1.  Differential activation of temporal cortex during sentence completion in schizophrenic patients with and without formal thought disorder.

Authors:  T T Kircher; E T Bulimore; M J Brammer; S C Williams; M R Broome; R M Murray; P K McGuire
Journal:  Schizophr Res       Date:  2001-05-30       Impact factor: 4.939

2.  Premorbid intellectual functioning in bipolar disorder and schizophrenia: results from a cohort study of male conscripts.

Authors:  Jari Tiihonen; Jari Haukka; Markus Henriksson; Mary Cannon; Tuula Kieseppä; Ilmo Laaksonen; Juhani Sinivuo; Jouko Lönnqvist
Journal:  Am J Psychiatry       Date:  2005-10       Impact factor: 18.112

Review 3.  Neuropsychology of bipolar disorder: a review.

Authors:  Seema Quraishi; Sophia Frangou
Journal:  J Affect Disord       Date:  2002-12       Impact factor: 4.839

Review 4.  A review of MRI findings in schizophrenia.

Authors:  M E Shenton; C C Dickey; M Frumin; R W McCarley
Journal:  Schizophr Res       Date:  2001-04-15       Impact factor: 4.939

5.  Effects of psychotic state and task demand on prefrontal function in schizophrenia: an fMRI study of overt verbal fluency.

Authors:  Cynthia H Y Fu; John Suckling; Steve C R Williams; Chris M Andrew; Goparlen N Vythelingum; Philip K McGuire
Journal:  Am J Psychiatry       Date:  2005-03       Impact factor: 18.112

6.  Overlooking the obvious: a meta-analytic comparison of digit symbol coding tasks and other cognitive measures in schizophrenia.

Authors:  Dwight Dickinson; Mary E Ramsey; James M Gold
Journal:  Arch Gen Psychiatry       Date:  2007-05

7.  The heritability of bipolar affective disorder and the genetic relationship to unipolar depression.

Authors:  Peter McGuffin; Fruhling Rijsdijk; Martin Andrew; Pak Sham; Randy Katz; Alastair Cardno
Journal:  Arch Gen Psychiatry       Date:  2003-05

Review 8.  Schizophrenia and personality: exploring the boundaries and connections between vulnerability and outcome.

Authors:  H Berenbaum; F Fujita
Journal:  J Abnorm Psychol       Date:  1994-02

9.  pLG72 modulates intracellular D-serine levels through its interaction with D-amino acid oxidase: effect on schizophrenia susceptibility.

Authors:  Silvia Sacchi; Mariagrazia Bernasconi; Magalie Martineau; Jean-Pierre Mothet; Maria Ruzzene; Mirella S Pilone; Loredano Pollegioni; Gianluca Molla
Journal:  J Biol Chem       Date:  2008-06-10       Impact factor: 5.157

10.  Neurocognitive deficit in schizophrenia: a quantitative review of the evidence.

Authors:  R W Heinrichs; K K Zakzanis
Journal:  Neuropsychology       Date:  1998-07       Impact factor: 3.295

View more
  17 in total

1.  Effect of Bcl-2 rs956572 SNP on regional gray matter volumes and cognitive function in elderly males without dementia.

Authors:  Mu-En Liu; Chu-Chung Huang; Jen-Ping Hwang; Albert C Yang; Pei-Chi Tu; Heng-Liang Yeh; Chen-Jee Hong; Ying-Jay Liou; Jin-Fan Chen; Ching-Po Lin; Shih-Jen Tsai
Journal:  Age (Dordr)       Date:  2011-12-25

Review 2.  G72 primate-specific gene: a still enigmatic element in psychiatric disorders.

Authors:  Silvia Sacchi; Giorgio Binelli; Loredano Pollegioni
Journal:  Cell Mol Life Sci       Date:  2016-02-25       Impact factor: 9.261

3.  A genome-wide sib-pair scan for quantitative language traits reveals linkage to chromosomes 10 and 13.

Authors:  P D Evans; K L Mueller; E R Gamazon; N J Cox; J B Tomblin
Journal:  Genes Brain Behav       Date:  2015-06       Impact factor: 3.449

Review 4.  Intermediate phenotypes in psychiatric disorders.

Authors:  Roberta Rasetti; Daniel R Weinberger
Journal:  Curr Opin Genet Dev       Date:  2011-03-04       Impact factor: 5.578

5.  Reduced cortical thickness is associated with the glutamatergic regulatory gene risk variant DAOA Arg30Lys in schizophrenia.

Authors:  C Christoph Schultz; Igor Nenadic; Kathrin Koch; Gerd Wagner; Martin Roebel; Claudia Schachtzabel; Thomas W Mühleisen; Markus M Nöthen; Sven Cichon; Thomas Deufel; Michael Kiehntopf; Marcella Rietschel; Jürgen R Reichenbach; Heinrich Sauer; Ralf G M Schlösser
Journal:  Neuropsychopharmacology       Date:  2011-04-20       Impact factor: 7.853

6.  Effect of D-amino acid oxidase activator (DAOA; G72) on brain function during verbal fluency.

Authors:  Diana P Prata; Sergio A Papagni; Andrea Mechelli; Cynthia H Y Fu; Joseph Kambeitz; Marco Picchioni; Fergus Kane; Sridevi Kalidindi; Colm McDonald; Eugenia Kravariti; Timothea Toulopoulou; Elvira Bramon; Muriel Walshe; Robin Murray; David A Collier; Philip K McGuire
Journal:  Hum Brain Mapp       Date:  2011-03-09       Impact factor: 5.038

7.  Increased neural activity during overt and continuous semantic verbal fluency in major depression: mainly a failure to deactivate.

Authors:  Heidelore Backes; Bruno Dietsche; Arne Nagels; Mirjam Stratmann; Carsten Konrad; Tilo Kircher; Axel Krug
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-02-21       Impact factor: 5.270

8.  Genotypic association of the DAOA gene with resting-state brain activity in major depression.

Authors:  Jun Chen; Yong Xu; Juan Zhang; Zhifen Liu; Cheng Xu; Kerang Zhang; Yan Shen; Qi Xu
Journal:  Mol Neurobiol       Date:  2012-08-01       Impact factor: 5.590

9.  A genome-wide supported psychiatric risk variant in NCAN influences brain function and cognitive performance in healthy subjects.

Authors:  Heidelore Raum; Bruno Dietsche; Arne Nagels; Stephanie H Witt; Marcella Rietschel; Tilo Kircher; Axel Krug
Journal:  Hum Brain Mapp       Date:  2014-09-13       Impact factor: 5.038

10.  Interaction between effects of genes coding for dopamine and glutamate transmission on striatal and parahippocampal function.

Authors:  Andreina Pauli; Diana P Prata; Andrea Mechelli; Marco Picchioni; Cynthia H Y Fu; Christopher A Chaddock; Fergus Kane; Sridevi Kalidindi; Colm McDonald; Eugenia Kravariti; Timothea Toulopoulou; Elvira Bramon; Muriel Walshe; Natascha Ehlert; Anna Georgiades; Robin Murray; David A Collier; Philip McGuire
Journal:  Hum Brain Mapp       Date:  2012-03-22       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.